Document is current
Any future updates will be listed below
-
Authors
Morka, Naomi https://orcid.org/0000-0002-1925-7223
Norris, Joseph M.
Emberton, Mark https://orcid.org/0000-0003-4230-0338
Kelly, Daniel https://orcid.org/0000-0002-1847-0655
- License Information
-
More Information
Article History
Received: 16 February 2021
Revised: 12 May 2021
Accepted: 27 May 2021
First Online: 18 June 2021
Competing interests
: JMN receives research funding from the MRC. Emberton receives funding from NIHR-i4i, MRC, Cancer Research UK, Jon Moulton Charitable Foundation, Sonacare Inc., Trod Medical, Cancer Vaccine Institute and Sophiris Biocorp for trials in prostate cancer. Emberton acts as a consultant, and/or trainer and proctor to Sonatherm Inc., Angiodynamics Inc. and Exact imaging Inc. The other authors declare no competing interests.
